Xiaoshi Zhang

2.6k total citations
75 papers, 1.5k citations indexed

About

Xiaoshi Zhang is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Xiaoshi Zhang has authored 75 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 23 papers in Immunology and 18 papers in Molecular Biology. Recurrent topics in Xiaoshi Zhang's work include Cancer Immunotherapy and Biomarkers (24 papers), Cutaneous Melanoma Detection and Management (16 papers) and CAR-T cell therapy research (16 papers). Xiaoshi Zhang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (24 papers), Cutaneous Melanoma Detection and Management (16 papers) and CAR-T cell therapy research (16 papers). Xiaoshi Zhang collaborates with scholars based in China, United States and France. Xiaoshi Zhang's co-authors include Rongbo Xiao, Guanhua Guo, Zhifeng Wu, Yingbiao Chen, Xiaonan Liu, Dandan Li, Xizhi Wen, Ya Ding, Ruiqing Peng and Yi‐Xin Zeng and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xiaoshi Zhang

70 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoshi Zhang China 21 699 433 375 241 178 75 1.5k
Núria Pardo Spain 19 595 0.9× 191 0.4× 249 0.7× 150 0.6× 227 1.3× 94 1.5k
Chengjun Zhou China 25 361 0.5× 144 0.3× 533 1.4× 76 0.3× 101 0.6× 94 1.5k
Atsushi Inagaki Japan 30 482 0.7× 763 1.8× 448 1.2× 928 3.9× 583 3.3× 105 2.7k
Michael R. Olson United States 23 233 0.3× 80 0.2× 384 1.0× 172 0.7× 179 1.0× 44 1.8k
Monica Mangoni Italy 24 760 1.1× 158 0.4× 353 0.9× 31 0.1× 164 0.9× 115 2.3k
Ann E. Perry United States 22 536 0.8× 133 0.3× 239 0.6× 33 0.1× 102 0.6× 53 1.4k
Vincent Crenn France 14 152 0.2× 65 0.2× 230 0.6× 100 0.4× 93 0.5× 71 990
Xiaohua Zhu China 24 334 0.5× 122 0.3× 273 0.7× 46 0.2× 55 0.3× 109 1.5k
Francesca Bruno Italy 18 52 0.1× 218 0.5× 282 0.8× 86 0.4× 81 0.5× 76 1.2k
Kevin Hu United States 10 177 0.3× 144 0.3× 385 1.0× 23 0.1× 38 0.2× 22 948

Countries citing papers authored by Xiaoshi Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaoshi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoshi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoshi Zhang more than expected).

Fields of papers citing papers by Xiaoshi Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoshi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoshi Zhang. The network helps show where Xiaoshi Zhang may publish in the future.

Co-authorship network of co-authors of Xiaoshi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoshi Zhang. A scholar is included among the top collaborators of Xiaoshi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoshi Zhang. Xiaoshi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niu, Jin, et al.. (2025). Single-frame multiwavelength coherent diffraction imaging using extreme ultraviolet high-harmonic comb sources. Chinese Optics Letters. 23(4). 40502–40502.
2.
Hou, Zhenlin, Weiwei Xiao, Qiaoqi Sui, et al.. (2025). Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study. npj Precision Oncology. 9(1). 237–237. 1 indexed citations
3.
Xiao, Qi, et al.. (2025). Ultra-broadband ptychography for dispersive samples. Nature Communications. 16(1). 5714–5714.
4.
Jing, Lin, Hui Wang, Weizhen Zhang, et al.. (2024). First-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced melanoma: Safety and efficacy results from a phase I study.. Journal of Clinical Oncology. 42(16_suppl). 9562–9562. 3 indexed citations
5.
Li, Kui, et al.. (2024). Multicolor wavefront sensing using Talbot effect for high-order harmonic generation. Physical Review Research. 6(4).
6.
Tang, Bixia, Rong Duan, Xiaoshi Zhang, et al.. (2024). Five-Year Follow-Up of POLARIS-01 Phase II Trial: Toripalimab as Salvage Monotherapy in Chinese Patients With Advanced Melanoma. The Oncologist. 29(6). e822–e827. 4 indexed citations
7.
Shen, Lujun, Juan Nie, Yiquan Jiang, et al.. (2024). Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy. Cancer Immunology Immunotherapy. 73(4). 68–68. 5 indexed citations
8.
Li, Dandan, Chao Chen, Jingjing Li, et al.. (2023). A pilot study of lymphodepletion intensity for peripheral blood mononuclear cell-derived neoantigen-specific CD8 + T cell therapy in patients with advanced solid tumors. Nature Communications. 14(1). 3447–3447. 6 indexed citations
9.
Xiao, Binyi, Xuan Zhang, Dandan Li, et al.. (2023). Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair–Deficient Colorectal Cancer. Journal of the National Comprehensive Cancer Network. 21(1). 60–66.e5. 26 indexed citations
10.
Lin, Qingyu, Tong Liu, Xingwen Wang, et al.. (2023). Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity. Journal of Clinical Investigation. 133(11). 23 indexed citations
11.
Shen, Lujun, Ying Wu, Han Qi, et al.. (2022). Inducible Regulatory T Cell Predicts Efficacy of PD‐1 Blockade Therapy in Melanoma. Advanced Therapeutics. 5(4). 2 indexed citations
12.
13.
Zhao, Jingjing, Dandan Li, Xinpei Deng, et al.. (2022). Nomogram for predicting prognosis of patients with metastatic melanoma after immunotherapy: A Chinese population–based analysis. Frontiers in Immunology. 13. 1083840–1083840. 22 indexed citations
14.
Wang, Qiaoxuan, Binyi Xiao, Yong Cheng, et al.. (2022). Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study. European Journal of Cancer. 174. 176–184. 19 indexed citations
15.
Xie, Jingyu, Yilin Song, Yuchuan Dai, et al.. (2021). Implanted microelectrode arrays for evaluating inhibited seizure modulated by light-responsive hydrogel. Journal of Micromechanics and Microengineering. 31(10). 105005–105005. 5 indexed citations
16.
Liu, Yina, Jiefeng Yang, Huan-he Ni, et al.. (2020). Hypoxia Induces Mitochondrial Defect That Promotes T Cell Exhaustion in Tumor Microenvironment Through MYC-Regulated Pathways. Frontiers in Immunology. 11. 1906–1906. 90 indexed citations
17.
Peng, Ruiqing, Chunyan Li, Xing-Juan Yu, et al.. (2011). Expression and clinical significance of high mobility group box 1 in stage IIIB colon cancer. Jiefangjun yixue zazhi. 36(3). 281–286. 1 indexed citations
18.
Zhang, Dongsheng, Wenqi Jiang, Xiaoshi Zhang, et al.. (2003). [Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].. PubMed. 22(8). 870–3. 5 indexed citations
19.
Zhang, Xiaoshi, et al.. (2003). The epidemiological investigation and analysis of endemic fluorosis in Guiyang from 2001 to 2002. 22(6). 525–527. 1 indexed citations
20.
Zhang, Xiaoshi, et al.. (2001). Relationship between polymorphism of Epstein-Barr virus-encoded small RNAs and nasopharyngeal carcinomas. 16(5). 301–303. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Núria Pardo Breakdown of academic impact, for papers by Chengjun Zhou Breakdown of academic impact, for papers by Atsushi Inagaki Breakdown of academic impact, for papers by Michael R. Olson Breakdown of academic impact, for papers by Monica Mangoni Breakdown of academic impact, for papers by Ann E. Perry Breakdown of academic impact, for papers by Vincent Crenn Breakdown of academic impact, for papers by Xiaohua Zhu Breakdown of academic impact, for papers by Francesca Bruno Breakdown of academic impact, for papers by Kevin Hu
Rankless by CCL
2026